Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcoma
Lauren Jia-Yi Li, Andreana Yang Leow, Joyce Chi, Maggie Yuxi Zhou, Nam Bui, Allison Pribnow, Kristen Ganjoo, Minggui Pan BJC Reports
· Springer Nature
· 2026-11-12
· DOI: 10.1038/s44276-026-00257-3
Аннотация
BJC Reports, Published online: 12 November 2026; doi:10.1038/s44276-026-00257-3 Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcoma
Lauren Jia-Yi Li, Andreana Yang Leow, Joyce Chi, Maggie Yuxi Zhou, Nam Bui, Allison Pribnow et al. Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcoma. // BJC Reports. – 2026. – DOI: 10.1038/s44276-026-00257-3. – URL: https://www.nature.com/articles/s44276-026-00257-3
Lauren Jia-Yi Li, Andreana Yang Leow, Joyce Chi, Maggie Yuxi Zhou, Nam Bui, Allison Pribnow, Kristen Ganjoo, & Minggui Pan (2026). Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcoma. BJC Reports. https://doi.org/10.1038/s44276-026-00257-3
Lauren Jia-Yi Li, et al. “Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcoma.” BJC Reports, 2026. doi:10.1038/s44276-026-00257-3.
@article{Li2026,
title = {Cabozantinib with or without immune checkpoint inhibition in heavily pretreated patients with advanced sarcoma},
author = {Li, Lauren Jia-Yi and Leow, Andreana Yang and Chi, Joyce and Zhou, Maggie Yuxi and Bui, Nam and Pribnow, Allison and Ganjoo, Kristen and Pan, Minggui},
journal = {BJC Reports},
year = {2026},
doi = {10.1038/s44276-026-00257-3},
url = {https://www.nature.com/articles/s44276-026-00257-3}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’